Bob Sinclair

Stanford University

Papers

1

Total Citations

49

H-Index

1

About

Bob Sinclair is a pioneering researcher at the forefront of biohybrid microrobotics, with a primary focus on developing living microalgae-based systems for precision medicine. His most notable contribution is the creation of "Volbots"—Volvox microalgae-based robots that enable multimodal precision imaging and therapy. This groundbreaking work, published in 2022 and already garnering 49 citations, addresses a critical limitation in cancer treatment: tumor hypoxia. By engineering these biohybrid microrobots to actively transport therapeutic payloads while overcoming hypoxic barriers, Sinclair has opened new avenues for more effective drug delivery. His research uniquely combines microalgae biology with robotics, demonstrating how living organisms can be harnessed as active, self-propelling therapeutic vehicles. The rapid citation count of his flagship paper underscores the field's recognition of his work's significance. Sinclair's achievements represent a major step forward in biohybrid microrobotics, offering a promising solution to enhance the therapeutic utility of targeted cancer treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
49
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Volbots: Volvox Microalgae‐Based Robots for Multimode Precision Imaging and Therapy
49 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Stanford University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago